Loading
TROG Cancer Research
The Australian and New Zealand radiation oncology trials group, which has run practice-changing trials of hypofractionation, stereotactic radiotherapy and radiation-drug combinations.
Also called: Trans Tasman Radiation Oncology GroupTROG
Overview
Founded in 1989 as the Trans Tasman Radiation Oncology Group and based in Newcastle, New South Wales, TROG is the cooperative group for radiation oncology across Australia and New Zealand. TROG 96.01 established short-course androgen deprivation with radiotherapy for locally advanced prostate cancer, CHISEL (TROG 09.02) showed stereotactic ablative radiotherapy beats conventional radiotherapy in inoperable early lung cancer, and TROG 12.01 tested de-escalation with cetuximab in HPV-positive oropharyngeal cancer. It co-ran PORTEC-3 in endometrial cancer and runs quality-assurance programmes for radiotherapy trials. TROG partners with ANZUP, AGITG and Breast Cancer Trials on multimodality studies.
Headquarters
Newcastle, NSW, AU
Website
Founded
1989
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-15.
Matched to Trans Tasman Radiation Oncology Group, including child institutions. 3 works · 0 citations · 67% open access · 67% clinical trials · 33% reviews.
Oncology works per year
02022
02023
02024
22025
12026
Most works
- Susan Harden2 works
- Harriet E. Gee2 works
- Margot Lehman2 works
- Catherine S. Bettington2 works
- Eric K.C. Hau2 works
- Bridget Rooney2 works
- Paul L.R. Mitchell1 works
- Marcus Cheng1 works
- Zhao Feng Liu1 works
- Sashendra Senthi1 works
Most cited
| Work | Journal | Year | Citations |
|---|---|---|---|
| Prophylactic Cranial Irradiation Versus Active MRI Surveillance in Small Cell Lung Cancer: Systematic Review and Meta‐Analysis | Journal of Medical Imaging and Radiation Oncology | 2026 | 0 |
| 1059P Consolidation thoracic radiotherapy with chemo-immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC):CHEST-RT (TROG 20.01) trial 10.1016/j.annonc.2025.10.770 | Annals of Oncology | 2025 | 0 |
| Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial – protocol for a phase II study 10.1136/bmjopen-2025-101571 · open access | BMJ Open | 2025 | 0 |
People
3Hien Le
President Elect and Chair of the Scientific Committee
Radiation oncologyClinical trialsProton therapy
Adelaide radiation oncologist who chairs TROG's Scientific Committee and is its President Elect.
Purnima Sundaresan
President
Radiation oncologyClinical trialsHealth services research
Sydney radiation oncologist who is President of TROG Cancer Research, Australasia's radiation oncology trials group.
Shankar Siva
Professor and Director of Radiation Oncology Research, Peter MacCallum Cancer Centre
Stereotactic radiotherapyKidney cancerOligometastatic disease
Radiation oncologist who established stereotactic radiotherapy as a non-surgical option for primary kidney cancer.
Notes
- Prostate radiotherapy and androgen deprivation (TROG 96.01, RADAR)
- SABR for early lung cancer (CHISEL)
- HPV-positive head and neck de-escalation
- Radiotherapy quality assurance
Connected
20Similar pages
- CompanyBreast Cancer Trials
Shares Cancer Council Australia, Peter MacCallum Cancer Centre and the tag cooperative-group.
- CompanyCanadian Cancer Trials Group (CCTG)
Shares CCTG CE.6 / EORTC 26062-22061 (Perry trial), SBRT / SABR (stereotactic radiotherapy) and the tag cooperative-group.
- CompanyKorean Gynecologic Oncology Group
Shares Endometrial cancer and the tag cooperative-group.
- CompanyDAHANCA
Shares Head and neck squamous cell carcinoma and the tag cooperative-group.
- CompanyGORTEC
Shares Head and neck squamous cell carcinoma and the tag cooperative-group.
- CompanyNRG Oncology
Shares Endometrial cancer, Head and neck squamous cell carcinoma, Prostate cancer and the tag cooperative-group.
- CompanyARCAGY-GINECO
Shares Endometrial cancer and the tag cooperative-group.
- CompanyEORTC
Shares CCTG CE.6 / EORTC 26062-22061 (Perry trial) and the tag cooperative-group.
cancers
fronts
technologies
companies
institutions
trials
people
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/